global rollercoast ride march main take today call despit
wba global retail pharmaci store remain open essenti busi relat
declin foot traffic due stay-at-hom restrict
pronounc neg impact global oper management note us sale
first week march significantli compstore march comp
sale actual turn neg rang uk comp trend also uninspir
march overal last day march possibl
global shelter place mandat may extend durat falloff either global rx
front-end product consum may gener shift higher use mail-ord
on-lin deliveri channel world-wide late march lower pharmaci sale mild
neg read us drug distributor may normal day wba result
also may neg read suggest barclay hc conf
sale trend posit current read late march sale trend
 front-end expect neg impact persist compani beauti
season categori suffer lower foot traffic groceri health
categori like see lift custom exhaust suppli time relat
remain uncertain long restrict remain place possibl
restrict local despit posit front-end comp model
return neg comp cost may elev management note
mln addit cost incur separ suppli side
prescript drug market remain steadi wba perspect minim risk
suppli shortag china/india stabl price trend among manufactur
cut pt estim prior estim alreadi saw us
low-end wba impli ep guidanc trim
see impact neg weigh us busi well
cut price target lower price-to-earnings
multipl ep equat ebitda
quarterli annual ep usd
lower usd
return equiti ttm
idc link barclay live interact chart
consensu number bloomberg receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
equal weight walgreen continu move
reinvent busi reimburs remain
headwind compani cost cut strategi
much reflect stock
upsid case see better expect cost
save better gross margin core us
busi rebound headwind
worsen lead multipl contract
continu headwind covid
note confer call
given current situat relat compani move resourc
away transform project delay roll-out sap us term
buy behavior within us manag indic increas demand
rx futur period declin beauti photo discretionari
categori within front-end portion busi foot traffic also drop
side march front sale strong lockdown across uk caus
sale turn neg oper side compani see higher expens
mln possibl mln due increas store safeti measur
sanit enhanc employe benefit higher suppli cost
higher cost relat suppli chain disrupt altogeth continu higher
cost may off-set benefit deriv higher sale
 quarterli retail drugstor data pharmacyactualactualactualactualactualactualprojectedprojectedu drugstor datastor beg number number per chang yr/yrtot per dataprescript sale usa per scriptrev per prescript rx chang yr/yrpharmaci rx store sale data pharmaci front-end drugstor barclay
 epsflat y/i /- y/i /- y/i /- growth yr/yrflatflatflatadjust tax mlnrepo mlnrepo mlnbalanc ep across halvesbalanc ep across halvesbalanc ep across halvesrx growth higher growth higher growth higher dev mln expens mln higher mln expens mln higher mln expens mln higher mln capit mln higher mln capit mln higher mln capit mln higher flat eps- adj effect tax net share op barclay
steve valiquett herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
barclay research produc invest bank barclay bank plc affili collect individu barclay
author contribut research report research analyst unless otherwis indic public date top report
reflect local time report produc may differ releas date provid gmt
avail disclosur
compani subject research report current import disclosur regard compani pleas refer
http //publicresearch barclay com altern send written request barclay research complianc seventh avenu floor
new york ny call
analyst respons prepar research report receiv compens base upon variou factor includ firm total
revenu portion gener invest bank activ profit revenu market busi
potenti interest firm invest client research respect asset class cover analyst
analyst regularli conduct site visit view materi oper cover compani barclay polici prohibit accept
payment reimburs cover compani travel expens visit
barclay research depart produc variou type research includ limit fundament analysi equity-link analysi
quantit analysi trade idea recommend contain one type barclay research may differ contain
type barclay research whether result differ time horizon methodolog otherwis
http //publicresearch barcap com/s/rd htm order access barclay research conflict manag polici statement pleas refer
procedur pleas
unless otherwis indic price sourc bloomberg reflect close price relev trade market may
last avail price time public
